BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3908132)

  • 1. Nifedipine in chronic bronchial asthma: a randomized double-blind crossover trial against placebo.
    Ozenne G; Moore ND; Leprevost A; Tardif C; Boismare F; Pasquis P; Lemercier JP
    Eur J Respir Dis; 1985 Oct; 67(4):238-43. PubMed ID: 3908132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with nifedipine in asthma: a randomized double-blind crossover trial.
    Lidji M; Molho M; Chagnac A; Katz I; Benzaray S
    Isr J Med Sci; 1988 Jan; 24(1):1-4. PubMed ID: 3279010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine treatment of patients with bronchial asthma.
    Patakas D; Maniki E; Tsara V; Dascalopoulou E
    J Allergy Clin Immunol; 1987 Jun; 79(6):959-63. PubMed ID: 3294978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
    Di Pasquale G; Lusa AM; Manini GL; Dominici P; Coluccini M; Bassein L; Pinelli G
    G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.
    Beskow R; Ericsson CH; Grönneberg R; Sjögren I; Skedinger M
    Eur J Respir Dis; 1984 Oct; 65(7):509-11. PubMed ID: 6386512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine].
    Klein W; Brandt D; Fluch N; Maurer E
    Z Kardiol; 1982 Jun; 71(6):398-405. PubMed ID: 6812301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD; Schwartz HJ; Rickard KA; Yancey SW; Swearingen BE
    J Fam Pract; 1998 Oct; 47(4):278-84. PubMed ID: 9789513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administered nifedipine in chronic stable asthma. Comparison with an orally administered sympathomimetic.
    Schwartzstein RS; Fanta CH
    Am Rev Respir Dis; 1986 Aug; 134(2):262-5. PubMed ID: 3740651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A; Martelli E; Bavera P; Agus GB
    Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of isoetharine mesylate in patients with chronic bronchial asthma.
    Schachter EN; Witek TJ; Beck GJ; Zuskin E; Tyler D
    Ann Allergy; 1986 Aug; 57(2):125-31. PubMed ID: 3526986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma and nifedipine. Comparison of nifedipine, ketotifen and placebo in the prophylaxis of childhood extrinsic asthma.
    Montoya F
    Allergol Immunopathol (Madr); 1988; 16(4):253-8. PubMed ID: 3067566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilazep vs. nifedipine in patients with stable effort angina. A double blind randomized study (author's transl)].
    Regoli F; Giusti C
    G Ital Cardiol; 1981; 11(12):2097-2104. PubMed ID: 7049819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of nifedipine on pollen-antigen-induced bronchoconstriction in asthmatics].
    Zhang XL
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):131-4, 190. PubMed ID: 2805141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J; Bookman AA; Mahon W; Ramsay C; Detsky AS; Keystone EC
    J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium channel blocker on blood pressure and respiratory function in patients with hypertension and asthma.
    Riska H; Stenius-Aarniala B; Sovijärvi AR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S79-81. PubMed ID: 2455149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.